Drug Shortage Report for JAMP-CHOLESTYRAMINE
| Report ID | 211780 |
| Drug Identification Number | 02478595 |
| Brand name | JAMP-CHOLESTYRAMINE |
| Common or Proper name | Cholestyramine for Oral Suspension |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | CHOLESTYRAMINE RESIN |
| Strength(s) | 4G |
| Dosage form(s) | POWDER FOR SUSPENSION |
| Route of administration | ORAL |
| Packaging size | 30 |
| ATC code | C10AC |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-11-27 |
| Estimated end date | 2024-06-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-02-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-02-06 | French | Compare |
| v4 | 2024-02-06 | English | Compare |
| v3 | 2024-01-30 | English | Compare |
| v2 | 2023-11-28 | French | Compare |
| v1 | 2023-11-28 | English | Compare |
Showing 1 to 5 of 5